PT - JOURNAL ARTICLE AU - Venkatesh, Samvida S. AU - Ganjgahi, Habib AU - Palmer, Duncan S. AU - Coley, Kayesha AU - Wittemans, Laura B. L. AU - Nellaker, Christoffer AU - Holmes, Chris AU - Lindgren, Cecilia M. AU - Nicholson, George TI - The genetic architecture of changes in adiposity during adulthood AID - 10.1101/2023.01.09.23284364 DP - 2023 Jan 01 TA - medRxiv PG - 2023.01.09.23284364 4099 - http://medrxiv.org/content/early/2023/01/11/2023.01.09.23284364.short 4100 - http://medrxiv.org/content/early/2023/01/11/2023.01.09.23284364.full AB - Obesity is a heritable disease, characterised by excess adiposity that is measured by body mass index (BMI). While over 1,000 genetic loci are associated with BMI, less is known about the genetic contribution to adiposity trajectories over adulthood. We derive adiposity-change phenotypes from 1.5 million primary-care health records in over 177,000 individuals in UK Biobank to study the genetic architecture of weight-change. Using multiple BMI measurements over time increases power to identify genetic factors affecting baseline BMI. In the largest reported genome-wide study of adiposity-change in adulthood, we identify novel associations with BMI-change at six independent loci, including rs429358 (a missense variant in APOE). The SNP-based heritability of BMI-change (1.98%) is 9-fold lower than that of BMI, and higher in women than in men. The modest genetic correlation between BMI-change and BMI (45.2%) indicates that genetic studies of longitudinal trajectories could uncover novel biology driving quantitative trait values in adulthood.Competing Interest StatementC.H. reports grants from Novo Nordisk and Novartis; C.M.L. reports grants from Bayer AG and Novo Nordisk and has a partner who works at Vertex. The other authors declare no conflicts of interest.Funding StatementS.S.V. is supported by the Rhodes Scholarship, Clarendon Fund, and the Medical Sciences Doctoral Training Centre at the University of Oxford. K.C. is supported by the University of Leicester (College of Life Sciences) and Health Data Research UK. L.B.L.W. is supported by the Wellcome Trust (221651/Z/20/Z). C.H. is supported by the Alan Turing Institute, the EPSRC grant Bayes4Health, Novartis, and Novo Nordisk. C.M.L. is supported by the Li Ka Shing Foundation, NIHR Oxford Biomedical Research Centre, Oxford, NIH (1P50HD104224-01), Gates Foundation (INV-024200), and a Wellcome Trust Investigator Award (221782/Z/20/Z). The research was supported by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z with additional support from the NIHR Oxford BRC. This research has been conducted using the UK Biobank Resource under Application Number 10844. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used data from the UK Biobank. UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. This approval means that researchers do not require separate ethical clearance and can operate under the RTB approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll generated summary statistics from GWAS will be made publicly available through the GWAS Catalog upon publication. All code required to reproduce analyses will be made publicly available at: https://github.com/lindgrengroup/longitudinal_primarycare/tree/main/adiposity/scripts/manuscript.